Yoseph Shaaltiel
2013
In 2013, Yoseph Shaaltiel earned a total compensation of $1.1M as Executive Vice President, Research and Development at Protalix BioTherapeutics, a 33% decrease compared to previous year.
Compensation breakdown
| Bonus | $120,000 |
|---|---|
| Option Awards | $140,770 |
| Salary | $302,901 |
| Stock Awards | $429,927 |
| Other | $81,672 |
| Total | $1,075,270 |
Shaaltiel received $429.9K in stock awards, accounting for 40% of the total pay in 2013.
Shaaltiel also received $120K in bonus, $140.8K in option awards, $302.9K in salary and $81.7K in other compensation.
Rankings
In 2013, Yoseph Shaaltiel's compensation ranked 6,269th out of 12,286 executives tracked by ExecPay. In other words, Shaaltiel earned more than 49.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,269 out of 12,286 | 49th |
Division Manufacturing | 2,192 out of 4,612 | 53rd |
Major group Chemicals And Allied Products | 651 out of 1,462 | 56th |
Industry group Drugs | 471 out of 1,156 | 59th |
Industry Biological Products, Except Diagnostic Substances | 73 out of 196 | 63rd |
Source: SEC filing on July 1, 2016.
Shaaltiel's colleagues
We found four more compensation records of executives who worked with Yoseph Shaaltiel at Protalix BioTherapeutics in 2013.